T1	PROC 46 72	Estudio de no inferioridad
#1	AnnotatorNotes T1	C4505128; Non-Inferiority Trial; Research Activity
T2	CHEM 87 93	Daflon
#2	AnnotatorNotes T2	C0215217; Daflon; Organic Chemical · Pharmacologic Substance
T3	CHEM 141 147	Daflon
#3	AnnotatorNotes T3	C0215217; Daflon; Organic Chemical · Pharmacologic Substance
T4	PROC 200 211	tratamiento
#4	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	DISO 229 257	Insuficiencia Venosa Crónica
#5	AnnotatorNotes T5	C1306557; Chronic venous insufficiency; Disease or Syndrome
T6	DISO 259 262	IVC
#6	AnnotatorNotes T6	C1306557; Chronic venous insufficiency; Disease or Syndrome
T7	PROC 287 313	Estudio de no inferioridad
#7	AnnotatorNotes T7	C4505128; Non-Inferiority Trial; Research Activity
T8	CHEM 328 334	Daflon
#8	AnnotatorNotes T8	C0215217; Daflon; Organic Chemical · Pharmacologic Substance
T9	CHEM 382 388	Daflon
#9	AnnotatorNotes T9	C0215217; Daflon; Organic Chemical · Pharmacologic Substance
T10	PROC 441 452	tratamiento
#10	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	DISO 470 498	Insuficiencia Venosa Crónica
#11	AnnotatorNotes T11	C1306557; Chronic venous insufficiency; Disease or Syndrome
T12	DISO 500 503	IVC
#12	AnnotatorNotes T12	C1306557; Chronic venous insufficiency; Disease or Syndrome
T13	PROC 506 591	Estudio internacional, multicéntrico, doble ciego, aleatorizado, con grupos paralelos
T14	DISO 615 643	Insuficiencia Venosa Crónica
#13	AnnotatorNotes T14	C1306557; Chronic venous insufficiency; Disease or Syndrome
T15	DISO 692 738	insuficiencia venosa crónica (IVC) sintomática
T16	DISO 861 889	Insuficiencia venosa crónica
#14	AnnotatorNotes T16	C1306557; Chronic venous insufficiency; Disease or Syndrome
T17	ANAT 935 941	pierna
#15	AnnotatorNotes T17	C1140621; Leg; Body Part, Organ, or Organ Component | C1269079; Entire lower limb; Body Part, Organ, or Organ Component
T18	ANAT 243 249	Venosa
#16	AnnotatorNotes T18	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T19	ANAT 484 490	Venosa
#17	AnnotatorNotes T19	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T20	ANAT 629 635	Venosa
#18	AnnotatorNotes T20	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T21	ANAT 706 712	venosa
#19	AnnotatorNotes T21	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T22	ANAT 875 881	venosa
#20	AnnotatorNotes T22	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T23	Date 13 17	2012
T25	Dose 94 101	1000 mg
T26	Form 115 125	suspensión
#21	AnnotatorNotes T26	C4724031; Suspension Dosage Form; Biomedical or Dental Material
T27	Route 126 130	oral
#22	AnnotatorNotes T27	C1527415; Oral Route of Drug administration; Functional Concept
T28	Frequency 131 137	al día
T29	Dose 148 169	500 mg, 2 comprimidos
T31	Frequency 170 177	diarios
T32	Duration 184 196	ocho semanas
T33	LIVB 215 224	pacientes
#23	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	Duration 250 257	Crónica
#24	AnnotatorNotes T34	C0205191; chronic; Temporal Concept
T36	Dose 335 342	1000 mg
T37	Form 356 366	suspensión
#25	AnnotatorNotes T37	C4724031; Suspension Dosage Form; Biomedical or Dental Material
T38	Route 367 371	oral
#26	AnnotatorNotes T38	C1527415; Oral Route of Drug administration; Functional Concept
T39	Frequency 372 378	al día
T40	Dose 389 410	500 mg, 2 comprimidos
T42	Frequency 411 418	diarios
T43	Duration 425 437	ocho semanas
T44	LIVB 456 465	pacientes
#27	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	Duration 491 498	Crónica
#28	AnnotatorNotes T45	C0205191; chronic; Temporal Concept
T46	Duration 636 643	Crónica
#29	AnnotatorNotes T46	C0205191; chronic; Temporal Concept
T48	LIVB 670 687	Pacientes adultos
#30	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T49	Duration 713 720	crónica
#31	AnnotatorNotes T49	C0205191; chronic; Temporal Concept
T50	LIVB 766 774	Paciente
#32	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Age 778 796	entre 20 y 75 años
T52	LIVB 823 829	Hombre
#33	AnnotatorNotes T52	C0025266; Male population group; Population Group
T53	LIVB 832 837	mujer
#34	AnnotatorNotes T53	C0043210; Woman; Population Group
T54	LIVB 839 859	Paciente ambulatorio
#35	AnnotatorNotes T54	C0029921; Outpatients; Patient or Disabled Group
T55	Duration 882 889	crónica
#36	AnnotatorNotes T55	C0205191; chronic; Temporal Concept
T56	PHYS 1011 1019	Embarazo
#37	AnnotatorNotes T56	C0032961; Pregnancy; Organism Function
T57	PHYS 1021 1038	lactancia materna
#38	AnnotatorNotes T57	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T58	Spec_cue 1041 1055	posibilidad de
T59	Form 158 169	comprimidos
#39	AnnotatorNotes T59	C0039225; Tablet Dosage Form; Biomedical or Dental Material
T60	Form 399 410	comprimidos
#40	AnnotatorNotes T60	C0039225; Tablet Dosage Form; Biomedical or Dental Material
T62	PHYS 1065 1075	embarazada
#41	AnnotatorNotes T62	C0032961; Pregnancy; Organism Function
T24	PROC 965 983	clasificación CEAP
#42	AnnotatorNotes T24	[Clinical-Etiological-Anatomical-Pathophysiological classification]
T35	LIVB 1031 1038	materna
#43	AnnotatorNotes T35	C0026591; Mother (person); Family Group
A1	Population_data T48 Age
A2	Assertion T62 Speculated
T47	CONC 60 72	inferioridad
A3	Assertion T47 Negated
T61	CONC 301 313	inferioridad
A4	Assertion T61 Negated
T63	Neg_cue 298 300	no
T64	Neg_cue 57 59	no
R1	Negation Arg1:T64 Arg2:T47	
R2	Has_Dose_or_Strength Arg1:T2 Arg2:T25	
R3	Has_Drug_Form Arg1:T2 Arg2:T26	
R4	Has_Route_or_Mode Arg1:T2 Arg2:T27	
R5	Has_Frequency Arg1:T2 Arg2:T28	
R6	Has_Dose_or_Strength Arg1:T3 Arg2:T29	
R8	Has_Drug_Form Arg1:T3 Arg2:T59	
R9	Has_Frequency Arg1:T3 Arg2:T31	
R10	Has_Duration_or_Interval Arg1:T3 Arg2:T32	
R11	Has_Duration_or_Interval Arg1:T2 Arg2:T32	
R12	Used_for Arg1:T2 Arg2:T4	
R13	Used_for Arg1:T3 Arg2:T4	
R14	Experiences Arg1:T33 Arg2:T2	
R15	Experiences Arg1:T33 Arg2:T3	
R16	Experiences Arg1:T33 Arg2:T5	
R17	Location_of Arg1:T18 Arg2:T5	
R18	Location_of Arg1:T18 Arg2:T6	
R19	Has_Duration_or_Interval Arg1:T5 Arg2:T34	
R20	Has_Duration_or_Interval Arg1:T6 Arg2:T34	
R21	Negation Arg1:T63 Arg2:T61	
R22	Has_Dose_or_Strength Arg1:T8 Arg2:T36	
R23	Has_Drug_Form Arg1:T8 Arg2:T37	
R24	Has_Route_or_Mode Arg1:T8 Arg2:T38	
R25	Has_Frequency Arg1:T8 Arg2:T39	
R26	Has_Dose_or_Strength Arg1:T9 Arg2:T40	
R28	Has_Drug_Form Arg1:T9 Arg2:T60	
R29	Has_Frequency Arg1:T9 Arg2:T42	
R30	Has_Duration_or_Interval Arg1:T8 Arg2:T43	
R31	Has_Duration_or_Interval Arg1:T9 Arg2:T43	
R32	Used_for Arg1:T8 Arg2:T10	
R33	Used_for Arg1:T9 Arg2:T10	
R34	Experiences Arg1:T44 Arg2:T8	
R35	Experiences Arg1:T44 Arg2:T9	
R36	Experiences Arg1:T44 Arg2:T11	
R37	Location_of Arg1:T19 Arg2:T11	
R38	Location_of Arg1:T19 Arg2:T12	
R39	Has_Duration_or_Interval Arg1:T11 Arg2:T45	
R40	Has_Duration_or_Interval Arg1:T12 Arg2:T45	
R41	Has_Duration_or_Interval Arg1:T14 Arg2:T46	
R42	Location_of Arg1:T20 Arg2:T14	
R43	Location_of Arg1:T21 Arg2:T15	
R44	Has_Duration_or_Interval Arg1:T15 Arg2:T49	
R45	Experiences Arg1:T48 Arg2:T15	
R46	Has_Age Arg1:T50 Arg2:T51	
R47	Location_of Arg1:T22 Arg2:T16	
R48	Has_Duration_or_Interval Arg1:T16 Arg2:T55	
T65	Quantifier_or_Qualifier 890 898	primaria
#44	AnnotatorNotes T65	C0205225; Primary; Qualitative Concept
R49	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T65	
T66	Result_or_Value 919 922	C0s
T67	Result_or_Value 925 928	C4s
R50	Has_Result_or_Value Arg1:T24 Arg2:T67	
R51	Has_Result_or_Value Arg1:T24 Arg2:T66	
R52	Location_of Arg1:T17 Arg2:T24	
R53	Experiences Arg1:T35 Arg2:T57	
R54	Speculation Arg1:T58 Arg2:T62	
T68	PROC 1087 1094	estudio
#45	AnnotatorNotes T68	C0008976; Clinical Trials; Research Activity
R55	Overlap Arg1:T62 Arg2:T68	
R56	Overlap Arg1:T57 Arg2:T68	
R57	Overlap Arg1:T56 Arg2:T68	
R58	Experiences Arg1:T33 Arg2:T6	
R59	Experiences Arg1:T44 Arg2:T12	
A5	Experiencer T33 Patient
A6	Experiencer T44 Patient
A7	Experiencer T48 Patient
A8	Experiencer T50 Patient
A9	Experiencer T52 Patient
A10	Experiencer T53 Patient
A11	Experiencer T54 Patient
A12	Experiencer T35 Patient
